Explore FHI 360

Practice Area

Health

For FHI 360, improving the health of the world's women, men and children is core to our mission.

Published research

The China tuberculosis clinical trials consortium network: A model for international TB clinical trials capacity building

Publication

FHI 360: COVID-19 Response

This fact sheet details FHI 360’s capabilities and technical expertise related to epidemic prevention, preparedness, and detection and response in humanitarian and complex emergencies.

Feature

Are we ready for the next pandemic? A clinical trial for a Zika virus vaccine improves the odds

In this audio interview, Ted FitzGerald and Claudia Christian discuss the global community’s preparedness for the next pandemic and the lessons we have learned about rapidly setting up clinical trials in resource-limited countries.

Feature

The challenge of developing a clinical trial for an Ebola vaccine

The development of new vaccines and medicines is critical to responding to emerging health threats, such as Ebola. And, when lives are at stake, the response cannot be fast enough.

News

FHI 360's clinical trials expertise supports further development of a Zika virus vaccine

FHI 360 is providing monitoring services for a trial to evaluate a DNA vaccine for the Zika virus, which could protect healthy adults and adolescents.

Feature

Malaria and the impact of clinical research

In this audio interview, FHI 360’s Ted FitzGerald, Director of Global Research Services, interviews our Director of Clinical Research in Kenya, Ghiorghis (George) Belai, about the status of malaria research.

Feature

China Tuberculosis Clinical Trials Consortium will advance global TB knowledge

FHI 360 began the China Tuberculosis Clinical Trials Consortium to develop a TB clinical trials research platform that meets international standards and is able to enroll participants in global, multicenter studies.

Past Project

Regional Prospective Observational Research in Tuberculosis (RePORT) International Coordinating Center

FHI 360 leads the Regional Prospective Observational Research in Tuberculosis (RePORT) International Coordinating Center (RICC), which manages worldwide research teams.

Past Project

China Tuberculosis Clinical Trials Consortium (CTCTC) project

FHI 360’s China Tuberculosis Clinical Trials Consortium provides mentoring and advice on the critical aspects of maintaining a successful tuberculosis clinical trial network in China.

You are here

Search FHI 360

Practice Areas

Services

Content Types

Expertise Areas

Countries

Article Types

Resource Types

Health

The China tuberculosis clinical trials consortium network: A model for international TB clinical trials capacity building

FHI 360: COVID-19 Response

Are we ready for the next pandemic? A clinical trial for a Zika virus vaccine improves the odds

The challenge of developing a clinical trial for an Ebola vaccine

FHI 360's clinical trials expertise supports further development of a Zika virus vaccine

Malaria and the impact of clinical research

China Tuberculosis Clinical Trials Consortium will advance global TB knowledge

Regional Prospective Observational Research in Tuberculosis (RePORT) International Coordinating Center

China Tuberculosis Clinical Trials Consortium (CTCTC) project

You are here

Search FHI 360

Practice Areas

Services

Content Types

Expertise Areas

Countries

Article Types

Resource Types

Search within these results

11 Results Found